Le Lézard
Classified in: Health
Subjects: RCL, PSF

Updated Food Recall Warning (Allergen) - Certain Ottogi brand noodle products recalled due to undeclared egg

Product photos are available at https://bit.ly/2ARRtZt

OTTAWA, Jan. 11, 2019 /CNW/ - The food recall warning issued on November 16, 2018 has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation.

Industry is recalling certain Ottogi brand noodle products from the marketplace because they contain egg which is not declared on the label. People with an allergy to egg should not consume the recalled products described below.

The following products have been sold in British Columbia, Alberta, Saskatchewan, Ontario, and Quebec and may have been distributed in other provinces and territories.

Recalled products








Jin Ramen Spicy

600 g (120 g x 5)

Outer package: 6 45175 52015 3

Inner package: 6 45175 52012 2




Jin Ramen Mild

600 g (120 g x 5)

Outer package: 6 45175 52014 6

Inner package: 6 45175 52011 5




Snack Ramen

6 x 62 g

Outer package: 6 45175 92077 9

Inner package: 6 45175 57264 0




Jin Ramen Mild

120 g

6 45175 52011 5




What you should do

Check to see if you have recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.

If you have an allergy to egg, do not consume the recalled products as they may cause a serious or life-threatening reaction.


This recall was triggered by CFIA test results. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing recalled product from the marketplace.


There have been no reported reactions associated with the consumption of these products.

More information


SOURCE Canadian Food Inspection Agency (CFIA)

These press releases may also interest you

at 11:45
The FDA-cleared Lipogems procedure restores crucial cushioning for damaged tissue. It can be administered in the doctor's office as a stand-alone option to major, invasive surgery. For patients suffering from multiple orthopedic issues, their own fat...

at 11:43
NN, Inc., ("NN" or "the Company"), announced today that its NN Life Sciences group will exhibit at the 2019 Drug Delivery Partnerships (DDP), held January 28-30 in Palm Beach Gardens, Florida. The exhibit will mark the company's debut at DDP,...

at 11:42
According to new research published in the January 1, 2019 issue of the Journal of the American Academy of Orthopaedic Surgeons, trampoline parks and jump parks have been linked to a higher percentage of total fractures among pediatric and adult...

at 11:37
The International Safety Center, a woman-led global organization committed to improving the safety and health of those working in healthcare, this month released its 2017 Exposure Prevention Information Network (EPINet®) data illustrating for the...

at 11:30
The Brain & Behavior Research Foundation is hosting a free interactive webinar on "Early Detection and Prevention of Psychotic Disorders: Ready for Prime Time" on Tuesday, February 12, 2019, from 2pm to 3pm EST.  Jeffrey Lieberman, M.D., Professor...

at 11:27
Quest Diagnostics , the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2019 for the fourth consecutive year. ...

News published on 12 january 2019 at 00:07 and distributed by: